Why
Trelleborg faces an EU REACH restriction that puts two product lines out of compliance by 2027
value estimated without shipment data
Ranking plays against live signals…
Ranking plays against live signals…
Trelleborg
Trelleborg faces an EU REACH restriction that puts two product lines out of compliance by 2027
value estimated without shipment data
Trelleborg is developing a halogen-free alternative for its Medical Solutions platform
value estimated without shipment data
Trelleborg and Datwyler have formed an alliance that changes the qualification path
Trelleborg's recent patent activity points at a bio-based substitution programme
Trelleborg's Trelleborg site is operating under a consent order that constrains its current chemistry
Trelleborg and Datwyler have formed an alliance that changes the qualification path
Trelleborg is repositioning Industrial Solutions from volume toward specialty margin
value estimated without shipment data
Trelleborg has paused its buyback, freeing capital its CFO has tied to organic growth
Trelleborg's largest customer has set a supplier sustainability threshold Trelleborg cannot yet meet
Trelleborg has signalled an acquisition posture in adjacent materials
value estimated without shipment data
Trelleborg's Trelleborg site is operating under a consent order that constrains its current chemistry
Recall exposure in Trelleborg's Medical Solutions unit is forcing a reformulation review
value estimated without shipment data
Trelleborg is moving qualification authority from corporate R&D down to the plants
value estimated without shipment data
Trelleborg and Datwyler have formed an alliance that changes the qualification path
Trelleborg is exiting a segment it has described as non-core for three consecutive quarters
value estimated without shipment data
Trelleborg is moving qualification authority from corporate R&D down to the plants
Trelleborg raised debt this quarter earmarked for capacity in Medical Solutions
Trelleborg's Trelleborg site is operating under a consent order that constrains its current chemistry
Recall exposure in Trelleborg's Medical Solutions unit is forcing a reformulation review
value estimated without shipment data
Trelleborg's Trelleborg site is operating under a consent order that constrains its current chemistry
Trelleborg is committing capex to Wuxi at roughly twice its historical run rate
Trelleborg's recent patent activity points at a bio-based substitution programme
Trelleborg is repositioning Sealing Solutions from volume toward specialty margin
Trelleborg is repositioning Sealing Solutions from volume toward specialty margin
value estimated without shipment data
Trelleborg is moving qualification authority from corporate R&D down to the plants
Trelleborg has begun pilot production of a recycled-content grade at Wuxi
value estimated without shipment data
Freudenberg is taking share from Trelleborg in the segment your material serves
value estimated without shipment data
Trelleborg has signalled an acquisition posture in adjacent materials
Trelleborg is moving qualification authority from corporate R&D down to the plants